Trial Profile
Phase III, randomized, double-blind, active-controlled, parallel arm study of PRC-062 in patients with chronic non-cancer pain
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 20 Aug 2014
Price :
$35
*
At a glance
- Drugs Hydrocodone (Primary) ; PRC 062 (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors Purdue Pharma
- 20 Dec 2014 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 08 Jan 2014 New trial record